Atorvastatin Calcium Market Is Projected to Extend at a 250 Million USD by the End of 2025, with a CAGR of 6.0%: QY Research
QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
Los Angeles, CA -- (SBWire) -- 04/13/2019 --Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
Atorvastatin calcium refers to a pharmaceutical raw material in the production of atorvastatin calcium drug. It contains chemical synthesis type and biocatalysis type. The atorvastatin calcium industry is a concentrated group relatively, as production qualification of atorvastatin calcium is controlled by government.
India and China are the main consumption bases, and India holds 35.39% consumption share, and China holds 18.98% consumption share in 2015. They occupy 54.37% of the global consumption in total.
The global Atorvastatin Calcium market was 160 million US$ in 2018 and is expected to 250 million US$ by the end of 2025, growing at a CAGR of 6.0% between 2019 and 2025.
This report studies the Atorvastatin Calcium market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Get PDF of this report template: https://www.qyresearch.com/sample-form/form/966031/global-atorvastatin-calcium-market
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Atorvastatin Calcium in these regions, from 2014 to 2025, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Pfizer
DSM Sinochem Pharmaceuticals
Cadila Pharmaceuticals
Sun Pharmaceutical Industries
Dr. Reddy's
Morepen
Teva Pharmaceutical Industries
Apotex Pharmachem
Sandoz Inc
Mylan Pharmaceuticals Inc.
Kremers Urban Pharmaceuticals Inc.
ScieGen Pharmaceuticals, Inc.
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
By the product type, the market is primarily split into
Chemical Synthesis
Biocatalysis
Others
By the end users/application, this report covers the following segments
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others
Get Full Report Now at USD 3,350: https://www.qyresearch.com/settlement/pre/1bcd7abe70121b37ef5629bfb96c672a,0,1,Global%20Atorvastatin%20Calcium%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Manufacturers,%20Key%20Regions,%20Types%20and%20Application
Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Media Relations Contact
Rahul Singh
Director - Digital Marketing
QY Research, Inc.
1-626-295-2442
https://www.qyresearch.com/index/detail/966031/global-atorvastatin-calcium-market
View this press release online at: http://rwire.com/1195389